Physician profile
Frances Yu
NPI 1164050878
$978.39
in general payments reported to CMS, 2019-2025
10 companies · $672 in 2025
The $672 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $148 · 2024: $158 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $284.86 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Angiodynamics, INC. | $148.48 | 2023 | Venacure 1470 Pro |
| Medtronic, INC. | $138.42 | 2025 | Endurant Iis |
| Lifenet Health | $134.64 | 2025 | Theragenesis Wound Matrix |
| Convatec INC. | $125.55 | 2025 | |
| Lemaitre Vascular, INC. | $46.01 | 2025 | Trivex System |
| Smith+Nephew, INC. | $32.42 | 2025 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $31.51 | 2024 | Eliquis |
| Pfizer INC. | $23.59 | 2025 | |
| Cashflow Solutions, LLC | $12.91 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.